KKM Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Hold
13,941
2.66% 4
2025
Q4
$15M Buy
13,941
+9,135
+190% +$8.73M 2.66% 4
2025
Q3
$3.67M Buy
4,806
+718
+18% +$534K 1.15% 44
2025
Q2
$3.19M Buy
4,088
+1,017
+33% +$790K 1.11% 39
2025
Q1
$2.54M Sell
3,071
-256
-8% -$213K 1.07% 38
2024
Q4
$2.57M Buy
3,327
+386
+13% +$320K 1.07% 40
2024
Q3
$2.61M Buy
2,941
+222
+8% +$200K 1.29% 29
2024
Q2
$2.46M Buy
2,719
+85
+3% +$68K 1.16% 30
2024
Q1
$2.05M Buy
+2,634
New +$1.87M 1% 43

Other funds holding LLY

KKM Financial's LLY Position: Q1 2026 in Review

KKM Financial held its Eli Lilly (LLY) position steady in Q1 2026 at 13,941 shares worth $15M. The position accounts for 2.66% of the portfolio, ranked #4.

KKM Financial first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • KKM Financial held 13,941 shares of Eli Lilly worth $15M as of Q1 2026.
  • KKM Financial left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 2.66% of KKM Financial's portfolio in Q1 2026, its #4 holding.
  • KKM Financial first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on KKM Financial's 13F filing for Q1 2026, filed 15 May 2026.